Literature DB >> 30065577

Spironolactone Monotherapy in Special Population of Patients with Hypertension.

Armin Attar1, Kamran Aghasadeghi1.   

Abstract

Entities:  

Year:  2018        PMID： 30065577      PMCID： PMC6066943          DOI： 10.6515/ACS.201807_34(4).20180531A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  4 in total

1.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 2.  Spironolactone in congestive heart failure.

Authors:  J E Soberman; K T Weber
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 3.  Eplerenone for hypertension.

Authors:  Tina Sc Tam; May Hy Wu; Sarah C Masson; Matthew P Tsang; Sarah N Stabler; Angus Kinkade; Anthony Tung; Aaron M Tejani
Journal:  Cochrane Database Syst Rev       Date:  2017-02-28

4.  Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Armin Attar; Amir-Abbas Sadeghi; Fatemeh Amirmoezi; Kamran Aghasadeghi
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.